SETBP1 (SET binding protein 1) [PDF]
Review on SETBP1 (SET binding protein 1), with data on DNA, on the protein encoded, and where the gene is implicated.
Cristóbal, I +2 more
openaire +4 more sources
SETBP1dysregulation in congenital disorders and myeloid neoplasms [PDF]
Myeloid malignancies are characterized by an extreme molecular heterogeneity, and many efforts have been made in the past decades to clarify the mechanisms underlying their pathogenesis. In this scenario SET binding protein 1 (SETBP1) has attracted a lot of interest as a new oncogene and potential marker, in addition to its involvement in the Schinzel ...
COCCARO, NICOLETTA +5 more
openaire +5 more sources
The landscape of SETBP1 gene expression and transcription factor activity across human tissues.
The SET binding protein 1 (SETBP1) gene encodes a transcription factor (TF) involved in various cellular processes. Variants in SETBP1 can result in three different diseases determined by the introduction (germline vs.
Jordan H Whitlock +4 more
doaj +4 more sources
Expression and regulation of SETBP1 in the song system of male zebra finches (Taeniopygia guttata) during singing [PDF]
Rare de novo heterozygous loss-of-function SETBP1 variants lead to a neurodevelopmental disorder characterized by speech deficits, indicating a potential involvement of SETBP1 in human speech.
Dana Jenny Grönberg +5 more
doaj +6 more sources
SETBP1 mutations are associated with the Schinzel-Giedion syndrome (SGS), characterized by profound neurodevelopmental delay, typical facial features, and multiple congenital malformations (OMIM 269150).
Elisa Bettella +2 more
exaly +3 more sources
ObjectivesThis meta-analysis investigates the prognostic effect of SET binding protein 1 (SETBP1) mutations in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), or chronic neutrophilic leukemia (CNL).MethodsEligible ...
Li-Hong Shou +7 more
doaj +2 more sources
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia [PDF]
Atypical chronic myeloid leukemia (aCML) shares clinical and laboratory features with CML, but it lacks the BCR-ABL1 fusion. We performed exome sequencing of eight aCMLs and identified somatic alterations of SETBP1 (encoding a p.Gly870Ser alteration) in two cases.
PIAZZA, ROCCO GIOVANNI +27 more
openaire +5 more sources
SETBP1 mutations as a biomarker for myelodysplasia /myeloproliferative neoplasm overlap syndrome [PDF]
Myelodysplasia (MDS) /myeloproliferative neoplasm (MPN) overlap syndrome has been described since the 2001 WHO classification as disorders that have both proliferative and dysplastic changes simultaneously.
Katherine Linder +2 more
doaj +3 more sources
Atypical chronic myeloid leukemia: From diagnosis to molecular features and therapeutic options [PDF]
Atypical chronic myeloid leukemia (aCML) is a rare form of myelodysplastic (MDS)/myeloproliferative neoplasm (MPN) overlap disorder characterized by neutrophilic leukocytosis with circulating immature myeloid cells (IMC), frequent hepatosplenomegaly, and
Alessandra Iurlo +3 more
doaj +2 more sources
Identification of a Novel <i>KRAS::ETNK1</i> Fusion Transcript in a Myelodysplastic/Myeloproliferative Overlap Syndrome With Eosinophilia: A Case Report. [PDF]
ABSTRACT This work describes, to our knowledge, the first reported case of a patient with an MDS/MPN overlap syndrome harboring a novel KRAS::ETNK1 fusion transcript. The disease initially presented with eosinophilia, megakaryocyte expansion, mast cell infiltration, and a background of typical MDS/MPN‐associated mutations (ASXL1, TET2, EZH2, BCOR, and ...
Caledec M +17 more
europepmc +2 more sources

